Technical Analysis for CLNN - Clene Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 4.53 | 2.89% | 0.13 |
CLNN closed up 2.89 percent on Tuesday, November 19, 2024, on 15 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| NR7 | Range Contraction | 2.89% | |
| Lower Bollinger Band Walk | Weakness | 2.89% | |
| Wide Bands | Range Expansion | 2.89% | |
| Below Lower BB | Weakness | 2.89% |
| Alert | Time |
|---|---|
| Possible NR7 | about 3 hours ago |
| Possible Inside Day | about 3 hours ago |
| 60 Minute Opening Range Breakout | about 5 hours ago |
| Rose Above Previous Day's High | about 5 hours ago |
| Up 5% | about 5 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/05/2024
Clene Nanomedicine Inc., a biopharmaceutical company, develops technology solutions for drug development. The company develops Clean-Surface Nanosuspension, a technology that produces clean-surface nanocrystal medicines. Its technology also provides a platform for a pipeline of new drug candidates with application across a spectrum of diseases with unmet medical needs. The company focuses on demyelinating disorders and oncology. Clene Nanomedicine Inc. was incorporated in 2012 and is based in Salt Lake City, Utah.
Keywords: Biotechnology Biopharmaceutical Life Sciences Health Sciences Medication Technology Solutions Drug Development Nanomedicine
Classification
Keywords: Biotechnology Biopharmaceutical Life Sciences Health Sciences Medication Technology Solutions Drug Development Nanomedicine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 12.0 |
| 52 Week Low | 3.8181 |
| Average Volume | 68,738 |
| 200-Day Moving Average | 6.60 |
| 50-Day Moving Average | 5.37 |
| 20-Day Moving Average | 5.47 |
| 10-Day Moving Average | 5.10 |
| Average True Range | 0.49 |
| RSI (14) | 35.90 |
| ADX | 21.68 |
| +DI | 10.24 |
| -DI | 21.24 |
| Chandelier Exit (Long, 3 ATRs) | 5.03 |
| Chandelier Exit (Short, 3 ATRs) | 5.77 |
| Upper Bollinger Bands | 6.67 |
| Lower Bollinger Band | 4.27 |
| Percent B (%b) | 0.11 |
| BandWidth | 43.95 |
| MACD Line | -0.25 |
| MACD Signal Line | -0.08 |
| MACD Histogram | -0.1708 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.96 | ||||
| Resistance 3 (R3) | 4.94 | 4.78 | 4.89 | ||
| Resistance 2 (R2) | 4.78 | 4.67 | 4.79 | 4.87 | |
| Resistance 1 (R1) | 4.65 | 4.60 | 4.72 | 4.67 | 4.84 |
| Pivot Point | 4.49 | 4.49 | 4.52 | 4.50 | 4.49 |
| Support 1 (S1) | 4.36 | 4.38 | 4.43 | 4.38 | 4.21 |
| Support 2 (S2) | 4.20 | 4.31 | 4.21 | 4.19 | |
| Support 3 (S3) | 4.07 | 4.20 | 4.16 | ||
| Support 4 (S4) | 4.09 |
